Patient Preferences for Pharmaceutical and Device-based Treatments for Uncontrolled Hypertension: Discrete Choice Experiment.

Reduction in systolic BP was identified as the most important driver of patient treatment preference, while treatment-related risks had less influence. The results indicate that respondents would accept interventional treatments in exchange for modest reductions in systolic BP compared with those observed in renal denervation trials.